With our transparent pricing model, you will pay the same monthly rate regardless of your dosage for either medication
Long-term results differ from person to person Many people keep their progress when they stay on treatment because appetite control remains steady
For Medicare, Medicaid, or commercial policyholders, Klinic ensures you know insurance outcomes before beginning treatment, believing cost should not stand as a barrier to reaching weight loss goals
People with type 2 diabetes were excluded
However, you should not start taking this dose straight away
Marketed under the brand names Mounjaro (for diabetes) and Zepbound (for weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity), tirzepatide represents the first dual incretin receptor agonist available in clinical practice